These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity. Aylward JM J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of antimalarial drugs in systemic lupus erythematosus. Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401 [TBL] [Abstract][Full Text] [Related]
4. [Transitory retinopathy caused by prolonged treatment with hydroxychloroquine sulfate]. Chiari JJ; Freyberg RH Arch Med Panamenos; 1965 Apr; 14(1):23-32. PubMed ID: 5839434 [No Abstract] [Full Text] [Related]
5. Adherence to ophthalmologic monitoring for antimalarial toxicity in a lupus cohort. Bernatsky S; Pineau C; Joseph L; Clarke A J Rheumatol; 2003 Aug; 30(8):1756-60. PubMed ID: 12913931 [TBL] [Abstract][Full Text] [Related]
6. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study. Kobak S; Deveci H Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603 [TBL] [Abstract][Full Text] [Related]
7. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Wolfe F; Marmor MF Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788 [TBL] [Abstract][Full Text] [Related]
8. [Eye toxicity of antimalarial agents]. Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061 [TBL] [Abstract][Full Text] [Related]